Holy Stone Healthcare Co., Ltd. (TPEX:4194)
Taiwan · Delayed Price · Currency is TWD 6.53
+0.28 (4.48%)
Aug 4, 2026, 1:01 PM CST
Holy Stone Healthcare Market Cap
Holy Stone Healthcare has a market cap or net worth of 912.34 million as of August 4, 2026. Its market cap has decreased by -41.04% in one year.
Market Cap
912.34M
Enterprise Value
779.16M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.53
ChartMarket Cap Chart
Since December 13, 2013, Holy Stone Healthcare's market cap has decreased from 5.54B to 912.34M, a decrease of -83.55%. That is a compound annual growth rate of -13.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 912.34M | -18.83% |
| Dec 31, 2025 | 1.12B | -40.54% |
| Dec 31, 2024 | 1.89B | -21.47% |
| Dec 29, 2023 | 2.41B | -36.56% |
| Dec 30, 2022 | 3.79B | 20.29% |
| Dec 30, 2021 | 3.15B | 17.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LabTurbo Biotech | 1.10B |
| U-Neuron Biomedical | 1.09B |
| Bio Preventive Medicine | 1.07B |
| Level Biotechnology | 1.03B |
| GeneReach Biotechnology | 994.21M |
| Lukas Biomedical | 979.86M |
| TCI GENE | 899.59M |
| Meribank Biotech | 872.42M |